These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1843648)

  • 1. [The effect of tienamycin on selected cellular immunologic parameters in mice during the course of viral-bacterial infections of the respiratory system].
    Ciebiada I; Korczak E; Ferszt T; Denys A; Kowalska M
    Pneumonol Alergol Pol; 1991; 59(9-10):5-10. PubMed ID: 1843648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selected immune response parameters in respiratory tract infections in mice--effect of combined treatment with tienamycin and coparvax].
    Korczak E; Ciebiada I; Denys A
    Pneumonol Alergol Pol; 1996; 64(5-6):303-8. PubMed ID: 8924882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of roxithromycin on respiratory bacterial infection in mice.
    Gonokami Y; Konno S; Asano K; Kurokawa M; Kawazu K; Adachi M
    Arerugi; 1995 Jan; 44(1):45-9. PubMed ID: 7702454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of isoprinosine (ISO) on some cell immunity parameters in mice infected with influenza viruses and in mixed viral-bacterial infections. I. The release of the migration inhibiting factor from spleen leukocytes.
    Białek J; Denys A; Kowalska M; Szydłowska T
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):735-9. PubMed ID: 2421684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of cefoperazone on the activity of selected parameters of cellular immunity in mice with experimental viral-bacterial infection].
    Denys A; Kowalska M; Białek J; Szydłowska T
    Pol Tyg Lek; 1989 Apr; 44(17):387-9. PubMed ID: 2626359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect in viral-bacterial infection. 4. The leukocyte response to parainfluenza virus infection in the respiratory tract of mice, and the influence of antibiotics on the development of infection.
    Degré M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(1):88-94. PubMed ID: 4324936
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of isoprinosine (ISO) on some cell immunity parameters in mice infected with influenza viruses and in mixed viral-bacterial infections. II. Phagocytosis and bactericidal activity of granulocytes.
    Kowalska M; Denys A; Szydłowska T; Białek J
    Arch Immunol Ther Exp (Warsz); 1985; 33(6):741-53. PubMed ID: 2421685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programming of the lung in early life by bacterial infections predisposes to chronic respiratory disease.
    Starkey MR; Nguyen DH; Kim RY; Nair PM; Brown AC; Essifie AT; Horvat JC; Hansbro PM
    Clin Obstet Gynecol; 2013 Sep; 56(3):566-76. PubMed ID: 23722921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment of chest infections.
    Hickey BP
    Aust Fam Physician; 1977 Aug; 6(8):983-9. PubMed ID: 303513
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary defense mechanisms and the interaction between viruses and bacteria in acute respiratory infections.
    Jakab GJ
    Bull Eur Physiopathol Respir; 1977; 13(1):119-35. PubMed ID: 321050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of chronic recurrent respiratory tract infections].
    Nagatake T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):289-92. PubMed ID: 2615085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies].
    Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J
    Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309
    [No Abstract]   [Full Text] [Related]  

  • 14. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
    Noda K; Kodama S; Umemoto S; Nomi N; Hirano T; Suzuki M
    Microbiol Immunol; 2011 Aug; 55(8):574-81. PubMed ID: 21605159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies].
    Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F
    Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibacterial and immunomodulating therapy of respiratory tract diseases].
    Sil'vestrov VP; Karaulov AV
    Ter Arkh; 1983; 55(3):3-9. PubMed ID: 6344301
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro studies on cellular immunity in mice infected with influenza virus.
    Denys A; Białek J; Grzybowski A
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):541-5. PubMed ID: 749806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of pulmonary defense mechanisms against viral and bacterial infections by acute exposures to nitrogen dioxide.
    Jakab GJ
    Res Rep Health Eff Inst; 1988 Nov; (20):1-38. PubMed ID: 2855873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistant Haemophilus influenzae from respiratory tract infection in a tertiary care hospital in north India.
    Nag VL; Ayyagari A; Venkatesh V; Ghar M; Yadav V; Prasad KN
    Indian J Chest Dis Allied Sci; 2001; 43(1):13-7. PubMed ID: 11370501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect in viral-bacterial infection. 3. Histopathological changes in the trachea of mice following viral and bacterial infection.
    Degré M; Solberg LA
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(2):129-36. PubMed ID: 4325913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.